Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis

Clinical trial NCT01055899 · COMPLETED

Trial details

NCT number: NCT01055899
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2008-07-01
Primary completion: 2009-03-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.